Pharma manufacturer expands with purchase of facility in FranceApril 3, 2020A U.S.-based manufacturer of canine and equine joint health pharmaceuticals has expanded its capabilities with the purchase of a European active pharmaceutical ingredient (API) manufacturing plant.
SPONSORED CONTENTTake Control With ProHeart 12 (moxidectin)One dose offers year-long protection with a single injection, putting compliance in your hands. + Learn more